Longitudinal Sampling & Event-Based Collection
Get an all-inclusive perspective
Disease characteristics evolve, patient populations are heterogeneous, behavior and environment are dynamic. You need a detailed array of information and unique insight to changes over time to answer analytical questions reliably. But access to comprehensive sample types and datasets, plus support with clinically relevant study designs, may feel out of reach.
Our direct relationship with patients gives you the long-term access you need to complete longitudinal studies and procure biospecimens during key disease-associated pain events for a clinically useful view of biology.
Comprehensive Human Biospecimens & Data
Our longitudinal sampling capabilities are minimally invasive and can be supplemented with real-time data collection via customized methodologies that capture multidimensional concepts such as quality of life, health history, lifestyle factors, demographics, and socioeconomic measures.
Snapshot biospecimens from single moments in time are not enough to effectively translate research findings. Our conceptual framework with longitudinal sampling is all-inclusive and helps prevent expensive stumbles on the clinical stage.
Access to more than 70,000 patients nationwide
Medical record-verified eligibility
More than 90% study retention rate
Panoramic, long-term view of study participants
Salient, time-dependent insights reduce individual variability and increase statistical power
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 70,000 total members ready to advance science and medicine for the conditions they live with.
Get Samples for My Research
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, and International Conference on Harmonization (ICH).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.